Overview

Double-blind, Randomized Trial of PRAX-628 in Adults With Focal Seizures to Evaluate Efficacy and Safety (POWER1)

Status:
RECRUITING

Trial end date:
2025-12-08

Target enrollment:

Participant gender:

Summary

A Double-Blind, Randomized, Multicenter, Trial Evaluating the Efficacy and Safety of PRAX-628 in Adults With Focal Seizures (POWER1)

Phase:

PHASE2

Details

Lead Sponsor:

Praxis Precision Medicines